RO6874813

RO6874813 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO6874813, covering 2018-04-04 to 2018-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]